Skip to content
10-K

Annual Report

ProLung, Inc.

0001493152-23-012590

← back to feed
Filed
Apr 17, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Apr 17, 2023 4.59M sh
Stock Issued FY 2022 · Dec 31, 2022 19.41K sh
Capex FY 2022 · Dec 31, 2022 $3.9K
Capex FY 2022 · Dec 31, 2021 $2.14K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$2.27M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.8M
Cash And Equivalents FY 2022 · Dec 31, 2022 $296.5K
Cash And Equivalents FY 2022 · Dec 31, 2021 $745K
Stockholders Equity FY 2022 · Dec 31, 2022 −$13.05M
Stockholders Equity FY 2022 · Dec 31, 2021 −$11.55M
Stockholders Equity FY 2022 · Dec 31, 2020 −$8.85M
Current Liabilities FY 2022 · Dec 31, 2022 $13.5M
Current Liabilities FY 2022 · Dec 31, 2021 $12.44M
Total Liabilities FY 2022 · Dec 31, 2022 $13.58M
Total Liabilities FY 2022 · Dec 31, 2021 $12.44M
Current Assets FY 2022 · Dec 31, 2022 $296.5K
Current Assets FY 2022 · Dec 31, 2021 $745K
Total Assets FY 2022 · Dec 31, 2022 $534.57K
Total Assets FY 2022 · Dec 31, 2021 $884.12K
Eps Basic FY 2022 · Dec 31, 2022 −$0.97
Eps Basic FY 2022 · Dec 31, 2021 −$0.88
Sga Expense FY 2022 · Dec 31, 2022 $1.99M
Sga Expense FY 2022 · Dec 31, 2021 $1.72M
Rd Expense FY 2022 · Dec 31, 2022 $1.41M
Rd Expense FY 2022 · Dec 31, 2021 $761.05K
Net Income FY 2022 · Dec 31, 2022 −$4.36M
Net Income FY 2022 · Dec 31, 2021 −$3.62M
Operating Income FY 2022 · Dec 31, 2022 −$3.4M
Operating Income FY 2022 · Dec 31, 2021 −$2.48M